Last $10.25 USD
Change Today +0.10 / 0.99%
Volume 7.0K
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

muscle pharm corp (MSLP) Snapshot

Open
$10.30
Previous Close
$10.15
Day High
$10.50
Day Low
$10.05
52 Week High
10/8/14 - $14.20
52 Week Low
03/28/14 - $6.16
Market Cap
134.4M
Average Volume 10 Days
67.7K
EPS TTM
$-0.20
Shares Outstanding
13.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MUSCLE PHARM CORP (MSLP)

muscle pharm corp (MSLP) Related Bloomberg News

View More Bloomberg News

muscle pharm corp (MSLP) Related Businessweek News

No Related Businessweek News Found

muscle pharm corp (MSLP) Details

MusclePharm Corporation develops, manufactures, markets, and distributes branded nutritional supplements in the United States and internationally. It offers a range of powders, capsules, tablets, and gels. The company’s MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; MusclePharm core products comprise BCAA 3:1:2, CLA Core, and Fish Oil that balance the essentials to meet the day-in and day-out demands of athletes; and Arnold Schwarzenegger series physique supplements consist of protein gainers, muscle builders, multivitamins, and nitric oxide boosters. It also provides FitMiss, which is designed and formulated primarily for women lifestyle to cover various needs, including weight loss, multi-vitamins, protein shakes, detox, skin care, and pre-workout energy mixes. In addition, the company offers over-the-counter drugs and preparations, and cosmetics, as well as licenses its apparel line. MusclePharm Corporation sells its products to various fitness enthusiasts, such as football, combat sports, weight training, bodybuilding, runners, basketball, and soccer, as well as cross fit, golf, tennis, volleyball, outdoor activities, and athletic and recreational enthusiasts. The company was founded in 2008 and is headquartered in Denver, Colorado.

93 Employees
Last Reported Date: 10/31/14
Founded in 2008

muscle pharm corp (MSLP) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $510.0K
President and Director
Total Annual Compensation: $413.0K
Co-Founder and Executive Vice President of Br...
Total Annual Compensation: $310.0K
President of Sales & Marketing
Total Annual Compensation: $450.0K
Advisor
Total Annual Compensation: $410.0K
Compensation as of Fiscal Year 2013.

muscle pharm corp (MSLP) Key Developments

MusclePharm Corporation Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Maintains Earnings Guidance for the Full-Year 2014

MusclePharm Corporation reported unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, net sales increased 88.5% to $47.8 million from $25.3 million last year, primarily due to broadening distribution channels resulting in new customers, releasing new products, and development of strategic partnerships. Net income for the third quarter was $603,000, or $0.05 per diluted share, compared with a net loss of $3.9 million, or $0.47 per share, for the same period last year. Loss from operations was $4,537,455 compared to $4,872,780 a year ago. For the nine months, net income was $2.4 million, or $0.20 per diluted share, compared with a net loss of $13.7 million, or $2.07 per share, for the same period last year. Net sales increased 97% to $144.7 million from $73.4 million last year. Loss from operations was $2,976,893 compared to $8,335,192 a year ago. The company is maintaining its full-year revenue guidance for 2014 calling for net sales of approximately $185 to $195 million. The company is adjusting its earnings per share range to $0.20 to $0.22 per diluted share, in line with guidance issued at beginning of the year.

Muscle Pharm Corp. to Report Q3, 2014 Results on Nov 14, 2014

Muscle Pharm Corp. announced that they will report Q3, 2014 results at 5:00 PM, Eastern Standard Time on Nov 14, 2014

Muscle Pharm Corporation Announces the Resignation of Sydney Rollock as Chief Marketing and Sales Officer

Muscle Pharm Corporation announced that on October 14, 2014, Mr. Sydney Rollock resigned his position as Chief Marketing and Sales Officer of the company. Simultaneously with Mr. Rollock’s resignation as an employee of the company, Mr. Rollock and the company entered into a Separation and Release of Claims Agreement pursuant to which Mr. Rollock ended his employment with the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSLP:US $10.25 USD +0.10

MSLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natural Grocers by Vitamin Cottage Inc $22.48 USD 0.00
USANA Health Sciences Inc $105.66 USD -1.34
Vitamin Shoppe Inc $47.51 USD -0.59
View Industry Companies
 

Industry Analysis

MSLP

Industry Average

Valuation MSLP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MUSCLE PHARM CORP, please visit www.musclepharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.